Dong-Qing Wei Selected Research

Neoplasms (Cancer)

3/2024	Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer via cell-cell communication.
10/2023	ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
9/2023	Exploring the Binding Mechanism of NRG1-ERBB3 Complex and Discovery of Potent Natural Products to Reduce Diabetes-Assisted Breast Cancer Progression.
4/2023	Repositioning of experimentally validated anti-breast cancer peptides to target FAK-PAX complex to halt the breast cancer progression: a biomolecular simulation approach.
3/2023	Ranking Breast Cancer Drugs and Biomarkers Identification Using Machine Learning and Pharmacogenomics.
1/2023	Mutational Impacts on the N and C Terminal Domains of the MUC5B Protein: A Transcriptomics and Structural Biology Study.
1/2022	Sequence-structure functional implications and molecular simulation of high deleterious nonsynonymous substitutions in IDH1 revealed the mechanism of drug resistance in glioma.
3/2021	Potential Cancer- and Alzheimer's Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening.
1/2021	ACPS: An accurate bioinformatics tool for precision-based anti-cancer peptide generation via omics data.
1/2021	BC-TFdb: a database of transcription factor drivers in breast cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Qing Wei Research Topics

Disease

23	Infections 02/2024 - 10/2009
21	Neoplasms (Cancer) 03/2024 - 01/2018
13	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2005
11	COVID-19 04/2023 - 01/2021
10	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2019
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2021 - 01/2018
4	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2023 - 01/2018
4	Human Influenza (Influenza) 10/2013 - 10/2009
4	Severe Acute Respiratory Syndrome 01/2006 - 08/2003
3	Virus Diseases (Viral Diseases) 05/2024 - 05/2013
3	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2022
3	Reinfection 12/2023 - 11/2021
3	Inflammation (Inflammations) 03/2021 - 12/2019
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
3	Influenza in Birds (Avian Flu) 01/2021 - 05/2009
2	Liver Neoplasms (Liver Cancer) 03/2024 - 01/2020
2	Hypoxia (Hypoxemia) 01/2023 - 06/2021
2	Fever (Fevers) 01/2022 - 10/2021
2	Vomiting 01/2022 - 01/2022
2	Rupture 07/2021 - 10/2014
2	Hypersensitivity (Allergy) 06/2021 - 01/2020
2	Pain (Aches) 01/2020 - 05/2010
2	Chronic Disease (Chronic Diseases) 01/2020 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 03/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 10/2018
2	Drug-Related Side Effects and Adverse Reactions 02/2018 - 01/2009
2	Shock 07/2014 - 11/2012
1	Esophageal Neoplasms (Esophageal Cancer) 10/2023
1	Cholangiocarcinoma 01/2023
1	Anemia 01/2023
1	Breakthrough Infections 01/2023
1	Sepsis (Septicemia) 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Tuberculosis (Tuberculoses) 01/2023
1	Lassa Fever (Fever, Lassa) 11/2022

Drug/Important Bio-Agent (IBA)

24	VaccinesIBA 02/2024 - 01/2018
18	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2012
9	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2018
8	Peptides (Polypeptides)IBA 04/2023 - 02/2017
7	EnzymesIBA 01/2023 - 08/2003
6	LigandsIBA 11/2021 - 09/2009
5	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2020
5	Messenger RNA (mRNA)IBA 06/2021 - 10/2018
4	Amyloid (Amyloid Fibrils)IBA 05/2023 - 02/2017
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2018
4	EpitopesIBA 01/2022 - 01/2018
3	ProteomeIBA 03/2021 - 01/2019
3	Amantadine (Aman)FDA LinkGeneric 10/2013 - 10/2009
3	Rimantadine FDA LinkGeneric 10/2013 - 10/2009
3	rupintrivirIBA 05/2009 - 08/2003
2	ErbB Receptors (EGF Receptor)IBA 09/2023 - 06/2019
2	Dopamine (Intropin)FDA LinkGeneric 03/2023 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2021
2	Membrane Transport Proteins (Biological Pump)IBA 01/2023 - 01/2019
2	Amino Acids FDA Link 10/2022 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 10/2022 - 01/2022
2	Antimicrobial PeptidesIBA 11/2021 - 01/2021
2	AcetylcholinesteraseIBA 09/2021 - 03/2021
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2021 - 03/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 01/2018
2	Neuraminidase (Sialidase)IBA 01/2021 - 05/2009
2	Protein Subunit VaccinesIBA 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2020
2	lemairaminIBA 01/2020 - 11/2017
2	Long Noncoding RNAIBA 01/2020 - 01/2020
2	octogen (HMX)IBA 07/2014 - 11/2012
2	Protons (Proton)IBA 10/2013 - 05/2013
2	alpha7 Nicotinic Acetylcholine ReceptorIBA 02/2013 - 05/2009
2	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2008 - 09/2007
2	Peptide Hydrolases (Proteases)FDA Link 11/2004 - 08/2003
1	InterferonsIBA 05/2024
1	Neuregulin-1 (Neuregulin 1)IBA 09/2023
1	Growth Factor ReceptorsIBA 04/2023
1	IntegrinsIBA 04/2023
1	PaxillinIBA 04/2023
1	GoldIBA 03/2023
1	Furosemide (Lasix)FDA LinkGeneric 03/2023
1	PLX 4720IBA 03/2023
1	AZD 6244IBA 03/2023
1	mirdametinibIBA 03/2023
1	palbociclibIBA 03/2023
1	PanobinostatIBA 03/2023
1	tanespimycin (17AAG)IBA 03/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Scopolamine (Hyoscine)FDA Link 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	ZincIBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	AngiotensinogenIBA 11/2022
1	ReninIBA 11/2022

Therapy/Procedure

19	Therapeutics 03/2023 - 01/2006
3	Immunotherapy 03/2024 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2023
1	Immunomodulation 01/2023